Page last updated: 2024-10-15

3-hydroxykynurenine and Malaria

3-hydroxykynurenine has been researched along with Malaria in 1 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.

Research Excerpts

ExcerptRelevanceReference
"In Anopheles gambiae, the most efficient vector of the malaria parasite Plasmodium falciparum, 3-hydroxykynurenine is endowed with a toxic potential."3.91Study of Anopheles gambiae 3-hydroxykynurenine transaminase activity and inhibition by LC-MS/MS method. ( Canavesi, R; Del Grosso, E; Galli, U; Miggiano, R; Rizzi, M; Rossi, F; Stella, M, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canavesi, R1
Miggiano, R1
Stella, M1
Galli, U1
Rossi, F1
Rizzi, M1
Del Grosso, E1

Other Studies

1 other study available for 3-hydroxykynurenine and Malaria

ArticleYear
Study of Anopheles gambiae 3-hydroxykynurenine transaminase activity and inhibition by LC-MS/MS method.
    Journal of pharmaceutical and biomedical analysis, 2019, Sep-05, Volume: 173

    Topics: Animals; Anopheles; Enzyme Assays; Enzyme Inhibitors; Insecticides; Kynurenine; Malaria; Mosquito Ve

2019